14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $10.39 $16.25 Thursday, 25th Apr 2024 ZNTL stock ended at $10.99. This is 6.67% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 8.57% from a day low at $10.39 to a day high of $11.28.
90 days $10.39 $18.07
52 weeks $9.56 $31.46

Historical Zentalis Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Apr 25, 2024 $11.18 $11.28 $10.39 $10.99 1 077 395
Apr 24, 2024 $12.50 $12.59 $11.63 $11.77 736 918
Apr 23, 2024 $13.10 $13.46 $12.57 $12.57 379 195
Apr 22, 2024 $13.01 $13.32 $12.73 $13.00 445 807
Apr 19, 2024 $12.48 $13.07 $12.30 $12.96 1 007 765
Apr 18, 2024 $12.73 $12.94 $12.50 $12.54 678 124
Apr 17, 2024 $13.03 $13.31 $12.62 $12.71 809 909
Apr 16, 2024 $13.11 $13.36 $12.82 $12.88 394 426
Apr 15, 2024 $13.55 $13.77 $12.97 $13.27 683 731
Apr 12, 2024 $13.21 $14.07 $12.94 $13.41 728 544
Apr 11, 2024 $14.26 $14.45 $13.19 $13.41 918 169
Apr 10, 2024 $14.76 $15.06 $14.22 $14.73 810 629
Apr 09, 2024 $14.66 $15.78 $14.47 $15.74 895 245
Apr 08, 2024 $15.01 $15.12 $14.59 $14.62 469 167
Apr 05, 2024 $15.04 $15.33 $14.52 $15.08 377 746
Apr 04, 2024 $15.66 $16.21 $15.21 $15.32 685 752
Apr 03, 2024 $14.55 $15.69 $13.98 $15.62 501 732
Apr 02, 2024 $15.70 $15.76 $14.10 $14.43 1 127 893
Apr 01, 2024 $15.58 $16.25 $14.91 $16.13 555 950
Mar 28, 2024 $15.28 $16.08 $15.22 $15.76 579 811
Mar 27, 2024 $14.23 $15.24 $14.07 $15.19 570 396
Mar 26, 2024 $13.83 $14.36 $13.64 $14.09 455 914
Mar 25, 2024 $13.50 $14.02 $13.37 $13.58 650 011
Mar 22, 2024 $13.84 $13.85 $13.54 $13.65 336 067
Mar 21, 2024 $13.80 $14.26 $13.67 $13.71 436 864
Click to get the best stock tips daily for free!

About Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid tumors; Phase 1/2 clinical trial for the treatment of advanced solid tumors as a monotherapy and in an ... ZNTL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT